risk assessment, risk adjustment for healthcare payment. The search was limited to peer-reviewed articles since the year 2000, to maintain relevance to current day practices. Resuls were then screened on title and abstract, with a focus primarily on predictive modeling methodology and secondarily on background of risk adjustment policy and practice. The resulting papers were then reviewed in detail with full text assessment to evaluate their potential impact. Here we summarize the key findings from the highest impact articles.
Results and Discussion

Defining High risk patients
According to an expert panel from the Commonwealth Fund, high-need and high-cost (HCHN) patients are typically those with complex clinical conditions that limit their ability to care for themselves and should be the focus of federal initiatives to reduce costs [5, 6] . The top 5% of most costly patients contribute to approximately 50% of healthcare costs as shown consistently in literature. High-cost and high-need patients include patients with three or more chronic diseases with functional limitations that impact their self-care and routine activities of daily living. Most definitions include a behavioral or psychological component as one of the chronic diseases, and social determinants of health as well [7] .
Main aspects of predictive analytics
Some investigators consider adverse health events are random occurrences and question the validity of using previous utilization and cost data to predict future outcomes. It is theorized that those who have a serious medical event and receive active intervention, are typically are not the same that contribute to costs in the near future [8] . However, most would agree that individuals with multiple medical and behavioral comorbid chronic conditions and unmet social needs are at increased risk for adverse health events such as emergency department visits, hospitalizations and surgery. Models that rely on identifying patients in the upper quartiles of cost or utilization don't account for the principles of regression to the mean, i.e. most high-cost patients will improve even without intervention [8] . In contrast, predictive analytics that address the composite impact of various patient, organizational or system factors that predict adverse events and utilization can have superior results.
Claims vs. clinical data: A significant limitation of healthcare
data is that it is largely incomplete or inaccurate. Claims data is primarily generated for administrative and reimbursement purposes, whereas clinical documentation is an inexact source of data with significant user variability [8] . The literature shows there are evident limitations to relying on claims data in highrisk prediction, since administrative data is not representative of clinical risk [9] . Contrastingly, even though there are significant advantages to using EHR data, and review of literature shows that they are underutilized [10] .
Despite the limited availability of clinical data, there are incentives for providers to leverage EHR technology to make this data available. However, claims data is readily available and far more standardized than clinical data and most contemporary risk models are dependent on claims data. Comparing risk assessment tools that used a. patient demographics, b. self-reported outcomes and claims based methods to predict costs, claims based methods to be still more effective than the alternatives [11] . EHR data, even when available is frequently unstandardized and user dependent, and often incomplete or inaccurate [8] .
Big data methodologies: Although machine learning algorithms are increasingly used in healthcare, barriers to wider application include: 1. difficulties with feature selection, especially with respect to determining temporal correlation and 2. Inadequate explanation of prediction results that limits actional clinical applications. The slow adoption of machine learning is also attributed to the limited expertise of analysts in applying and interpreting these complex methodologies [12] . Kan 
